As precision medicine expands and whole exome sequencing becomes standard, it is critical to define a common framework to assess the evidence for gene-disease associations. Testing this framework involves reaching out to the experts in various specialties for validation. With input from the genetic community, genes can be transparently and systematically evaluated and prioritized for analysis in various clinical contexts.
In this webinar, Dr. DiStefano will discuss the current standards in place for exchanging gene-disease records, and the advantages of different databanks. The presentation will help healthcare IT managers be better prepared to support the integration of genomic data within clinical environments.